about
The Origin and Activities of IgA1-Containing Immune Complexes in IgA NephropathyCurrent Understanding of the Role of Complement in IgA NephropathyA diagnosis of haemolytic-uraemic syndrome blurred by alcohol abuse.MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?Serum cystatin C is a determinant of central pressure augmentation index measured by oscillometric method in renal transplant recipientsImmune profile of IgA-dominant diffuse proliferative glomerulonephritis.Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathyGWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathwayDetection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine.Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy.Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies.Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort.Diagnostic challenges of kidney diseases in HIV-infected patients.Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies.Common hepatic artery as inflow in kidney transplantation.KDIGO Guidelines and Kidney Transplantation: Is the Cystatin-C Based Recommendation Relevant?Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.Creatinine-based GFR predicting equations in renal transplantation: reassessing the tubular secretion effect.Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit.GFR estimation using standardized cystatin C in kidney transplant recipients.Solid-phase bead-based assays limitations are not restricted to interlaboratory variability.MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients.On the demanding necessity of properly evaluating renal graft function in clinical trials.Cystatin C-based equations in renal transplantation: moving toward a better glomerular filtration rate prediction?Creatinine calibration in NHANES: is a revised MDRD study formula needed?Renovascular hypertension: results in adulthood of renal autotransplantation performed in children.Deletion Variants of CFHR1 and CFHR3 Associate with Mesangial Immune Deposits but Not with Progression of IgA Nephropathy.Substantial superiority of Niobe ES over Niobe II system in remote-controlled magnetic pulmonary vein isolation.Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.Allocation of ECD kidneys based on donor GFR: the choice of the estimating equation matters.Estimated glomerular filtration rate as an end point in kidney transplant trial: where do we stand?[Exploration of renal glomerular function: estimation of glomerular filtration rate].Prognostic Value of Aortoiliac Calcification Score in Kidney Transplantation Recipients.Spontaneous splenic rupture in primary cytomegalovirus infection[Telemedicine: an unfruitful experience of tele-expertise in nephrology]Comparison of acid and enzymatic methods for inulin dosage: analytical performances and impact on glomerular filtration rate evaluation[Measurement of inulin: development]Trimethoprim, creatinine and creatinine-based equationsOverweight/obesity revisited as a predictive risk factor in primary IgA nephropathyRate of renal graft function decline after one year is a strong predictor of all-cause mortality
P50
Q26752555-5469823D-5BBF-4575-B099-096D8C50DF52Q26852163-025BBBFD-741E-41CA-9B0F-897DA9DD5074Q33419491-298330AC-C5DD-458D-AF69-718A043C9594Q33591792-298096DC-28D7-4828-8F9B-BCAD86D539F3Q34940161-E9F6DBDB-3FD4-47CE-8D96-704EFC3A0F99Q35232158-010EAF76-72F3-4370-9AFD-31EC05E066DDQ36200922-CFE0239F-7585-4415-B50A-F9533974A67FQ36276884-6B7FC614-6369-43AA-BB0A-BFA5A7823BD9Q37484757-8656A452-161D-406D-BA3E-2ED31370AEB4Q38843422-E57725A1-4366-442A-B1E1-B1C8A25CA300Q38965721-64F891CB-E46C-4384-8BFA-A2B9F10FF617Q39015440-0D7C9171-66DA-4D20-9514-B67847409E1EQ40051440-C06B8581-67AC-49A6-B190-B9B1476DAD27Q40637869-2262272A-F445-47E3-8C0E-FC7747134C5EQ40815063-FF999A9D-E96D-4574-8A85-546B230286ACQ41161771-2B4DDFEF-8BCA-40BB-B461-34A05B9D69DFQ42282597-4AD5FA4B-072B-46F0-8FE1-448298E8A733Q43119706-A4AFE653-6E50-4F4B-A9D4-9B8AE24E3CB3Q43198338-C3A11145-4756-452C-8B38-50CEFA616CB6Q43551685-9D4925C7-1DA8-4A69-8032-1BC90ED5AA53Q43583193-997C55E0-7AB0-4E8A-A2BD-72142BFFE7EAQ45307141-5DA28B78-E56C-4D2F-8B5F-49AE331C835AQ46396166-9CC3A56E-C8E8-4945-901C-1ECEAF40E073Q46518645-5A7EFF0C-F2BF-42EB-83F5-295533F1A2FEQ46678600-7AB9FA62-47A8-41D4-AB8B-B6187C460209Q47389763-E1997F69-C1C9-42D3-9FB6-A52F92828310Q47428540-C1C611C3-B219-48D9-925F-0A1A0ADB599FQ47903252-A42C5060-4823-4120-9CC8-755714D57281Q50864383-9CA83994-23A8-4826-80F0-D0E08D38753AQ51710854-E9619A76-CEB4-4E0B-9C47-16C72CC63483Q51902184-F2115240-2A4C-4422-BD9D-12A727254CC5Q52389142-E56C686E-5D23-42A7-A528-A778314DA1AFQ54677132-EC749C78-D11A-482E-B28A-4FFC043DA112Q79960510-0B5E7571-01FC-4281-B85F-83938E5DDA24Q82869663-EEA68823-B99D-47CA-B26C-24FB9D581EC4Q82879290-F3BDDBA1-0B44-4B92-AF6C-501462819163Q84320685-F7F41D90-FB1F-4157-A358-3725BC904EB7Q84742582-98AF479E-0C47-41AF-869C-C8CC540BD7E9Q85735167-15A4597D-F306-4948-83B9-E3996A4678F8Q85890748-7539ED8C-E81F-4912-998C-4234E56FCEB1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicolas Maillard
@ast
Nicolas Maillard
@en
Nicolas Maillard
@es
Nicolas Maillard
@nl
type
label
Nicolas Maillard
@ast
Nicolas Maillard
@en
Nicolas Maillard
@es
Nicolas Maillard
@nl
prefLabel
Nicolas Maillard
@ast
Nicolas Maillard
@en
Nicolas Maillard
@es
Nicolas Maillard
@nl
P106
P1153
36887684700
P21
P31
P496
0000-0002-3073-7252